Form 8-K - Current report:
SEC Accession No. 0000950123-01-001452
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
8
Period of Report
2001-01-08
Items
Item 5: Other events
Item 7: Financial statements and exhibits
Item 9: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT y45494e8-k.txt 8-K 14576
2 STOCK PURCHASE AGREEMENT y45494ex4-1.txt EX-4.1 81330
3 STOCK PURCHASE AGREEMENT y45494ex4-2.txt EX-4.2 81462
4 DEVELOPMENT AND MARKETING COLLABORATION AGREEMENT y45494ex10-1.txt EX-10.1 170544
5 DEVELOPMENT COLLABORATION AND LICENSING AGREEMENT y45494ex10-2.txt EX-10.2 124620
6 TRIPARTATE AGREEMENT y45494ex10-3.txt EX-10.3 58514
7 PRESS RELEASE y45494ex99-1.txt EX-99.1 7185
8 PRESS RELEASE y45494ex99-2.txt EX-99.2 12504
  Complete submission text file 0000950123-01-001452.txt   553268
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 1545908
SIC: 2835 In Vitro & In Vivo Diagnostic Substances